Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma

Recently, immunotherapy combined with targeted therapy has significantly prolonged the survival time and improved the quality of life of patients with hepatocellular carcinoma (HCC). However, HCC treatment remains challenging due to the high heterogeneity of this malignancy. Sorafenib, the first-lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ze, Zhang, Wenwen, Wang, Yafei, Wan, Tao, Hu, Bingyang, Li, Chonghui, Ge, Xinlan, Lu, Shichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919262/
https://www.ncbi.nlm.nih.gov/pubmed/35295858
http://dx.doi.org/10.3389/fcell.2022.792676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919262/
https://www.ncbi.nlm.nih.gov/pubmed/35295858
http://dx.doi.org/10.3389/fcell.2022.792676

Ejemplares similares